Ledger.Open graph →
SEC Form D · filed May 6, 2019

Vividion Therapeutics, Inc

Offering
$82.0M
Sold
$82.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jakob E. Loven · San Diego, CADirectorKristina L. Burow · San Diego, CADirectorRichard L. Heyman · San Diego, CADirectorJohn L. Clarke · San Diego, CADirectorBenjamin L. Cravatt · San Diego, CADirectorThomas E. Woiwode · San Diego, CADirectorFred K. Aslan · San Diego, CAExecTom K. Daniel · San Diego, CADirectorAmit Patel · SAN FRANCISCO, CADirectorBryan Staff · NEW YORK, NYDirectorMatt Brinker · NEW YORK, NYDirectorVictor Patterson · SAN FRANCISCO, CADirectorDavid Mrazik · NEW YORK, NYDirectorTim Bello · NEW YORK, NYDirectorDiego K. Miralles · San Diego, CAExec · DirectorCarmichael J. Roberts · Boston, MADirectorAdam Sharkawy · Boston, MADirectorChad Milam · Culver City, CADirectorVasa Babic · Culver City, CADirectorDavid Ward · Culver City, CADirectorHuanhuan Gilmore · Culver City, CADirectorDiego K. Miralles · San Diego, CAExec · DirectorFred K. Aslan · San Diego, CAExecTom K. Daniel · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗